Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 2;13(1):68.
doi: 10.1007/s12672-022-00534-w.

A novel diagnostic model for insulinoma

Affiliations

A novel diagnostic model for insulinoma

Feng Wang et al. Discov Oncol. .

Abstract

The aim is to describe a simple and feasible model for the diagnosis of insulinoma. This retrospective study enrolled 37 patients with insulinoma and 44 patients with hypoglycemia not due to insulinoma at the First Affiliated Hospital of Guangxi Medical University. General demographic and clinical characteristics; hemoglobin A1c (HbA1c), insulin and C-peptide concentrations; and the results of 2-h oral glucose tolerance tests (OGTT) were recorded, and a logistic regression model predictive of insulinoma was determined. Body mass index (BMI), HbA1c concentration, 0-h C-peptide concentration, and 0-h and 1-h plasma glucose concentrations (P < 0.05 each) were independently associated with insulinoma. A regression prediction model was established through multivariate logistics regression analysis: Logit p = 7.399+(0.310 × BMI) - (1.851 × HbA1c) - (1.467 × 0-h plasma glucose) + (1.963 × 0-h C-peptide) - (0.612 × 1-h plasma glucose). Using this index to draw a receiver operating characteristic (ROC) curve, the area under the curve (AUC) was found to be 0.957. The optimal cut-off value was - 0.17, which had a sensitivity of 89.2% and a specificity of 86.4%. Logit P ≥ - 0.17 can be used as a diagnostic marker for predicting insulinoma in patients with hypoglycemia.

Keywords: Diagnostic predictive model; Hypoglycemia; Insulinoma.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflicts of interest regarding the publication of this paper.

Figures

Fig. 1
Fig. 1
Flowchart of the sample selection
Fig. 2
Fig. 2
Diagnostic efficacy of the Logit P model, Fajans’ index, Turner’s index and verification of two models. Fajans’ index = immunoreactive insulin/glucose; Turner’s index = insulin * 100/(glucose − 30). Liao’s model = 8.305–0.441 * insulin 2 h/0 h ratio − 1.679 * C-peptide 1 h/0 h ratio. FPG*HBA1C index = FPG*HBA1C. PPV, positive predictive value; NPV, negative predictive value; AUC, area under the curve; CI, confidence interval. #: Validated model

Similar articles

Cited by

References

    1. Morera J, Reznik Y. Insulinoma. Rev Prat. 2019;69:e250–0. - PubMed
    1. Tuzcu SA, Pekkolay Z, Kilinc F, Tuzcu AK. 68Ga-DOTATATE PET/CT can be an alternative imaging method in insulinoma patients. J Nucl Med Technol. 2017;45:198–200. doi: 10.2967/jnmt.117.192708. - DOI - PubMed
    1. Vaidakis D, Karoubalis J, Pappa T, Piaditis G, Zografos GN. Pancreatic insulinoma: current issues and trends. Hepatobiliary Pancreat Dis Int. 2010;9:234–41. - PubMed
    1. Larijani B, Aghakhani S, Lor SSM, Zahedi F, Pajouhi M, et al. Insulinoma in Iran: a 20-year review. Ann Saudi Med. 2005;25:477–80. doi: 10.5144/0256-4947.2005.477. - DOI - PMC - PubMed
    1. Ma H, Zhang XP, Zhang Y, Lu HD, Wang JT, et al. Pancreatic Insulinoma misdiagnosed as epilepsy for eight years: a case report and literature review. Intern Med. 2015;54:1519–22. doi: 10.2169/internalmedicine.54.3708. - DOI - PubMed

LinkOut - more resources